Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Both slow-release and regular-form metformin improve glycemic control without altering plasma visfatin level in patients with type 2 diabetes mellitus

Published:2007-08 Issue:8 Volume:56 Page:1087-1092
ISSN:0026-0495
Container-title:Metabolism
language:en
Short-container-title:Metabolism

Author:

Hsieh Chang-Hsun,He Chih-Tseung,Lee Chien-Hsing,Wu Ling-Yi,Hung Yi-Jen

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Reference42 articles.

1. Metformin: an update;Kirpichnikov;Ann Intern Med,2002

2. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34);Lancet,1998

3. Adipose tissue as an endocrine organ;Kershaw;J Clin Endocrinol Metab,2004

4. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans;Berndt;Diabetes,2005

5. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes;Castell;FEBS Lett,1998

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metformin extended-release versus metformin immediate-release for adults with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials;Diabetes Research and Clinical Practice;2021-08

2. Efficacy and Side Effect Profile of Different Formulations of Metformin: A Systematic Review and Meta-Analysis;Diabetes Therapy;2021-06-02

3. Visfatin: A Possible Role in Cardiovasculo-Metabolic Disorders;Cells;2020-11-09

4. Investigating the changes in the levels of HbA1c, blood fat and insulin sensitivity in elder patients with type II diabetes mellitus due to combined medication of pioglitazone and melbine and single-use of pioglitazone;Cellular and Molecular Biology;2020-09-30

5. Therapeutic host-directed strategies to improve outcome in tuberculosis;Mucosal Immunology;2019-11-26